Arkolith/Insider Trading/OTLK/Form 4

Sukhtian Ghiath M.

Director, 10% OwnerOutlook Therapeutics, Inc. (OTLK) · full profile →Form 4 · filed Jun 1, 2026
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
7
1 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 28, 2026Buy(P)8.5M$0.59$5.0M22.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2026Expiration(H)3.5M——0
May 28, 2026Buy(P)3.5M——3.5M
May 28, 2026Expiration(H)3.5M——0
May 28, 2026Buy(P)3.5M——3.5M
May 28, 2026Expiration(H)8.6M——0
May 28, 2026Buy(P)8.6M——8.6M

Transaction Codes

P
Open-market purchase
H
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899140-26-000620) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML